C4 Therapeutics (CCCC) News Today $1.52 +0.04 (+2.70%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$1.50 -0.02 (-1.38%) As of 07/7/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CCCC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period SG Americas Securities LLC Buys Shares of 425,096 C4 Therapeutics, Inc. (NASDAQ:CCCC)June 21, 2025 | marketbeat.comC4 Therapeutics: An Entry Point If There's Ever Going To Be OneJune 16, 2025 | seekingalpha.comMillennium Management LLC Has $1.30 Million Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC)June 5, 2025 | marketbeat.comTwo Sigma Investments LP Cuts Position in C4 Therapeutics, Inc. (NASDAQ:CCCC)June 2, 2025 | marketbeat.comTwo Sigma Advisers LP Sells 181,200 Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC)May 28, 2025 | marketbeat.comBank of America Corp DE Reduces Stake in C4 Therapeutics, Inc. (NASDAQ:CCCC)May 28, 2025 | marketbeat.comSoleus Capital Management L.P. Has $25.12 Million Stock Position in C4 Therapeutics, Inc. (NASDAQ:CCCC)May 21, 2025 | marketbeat.comTang Capital Management LLC Boosts Stock Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC)May 20, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Sells 353,861 Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC)May 20, 2025 | marketbeat.comQ2 EPS Estimates for C4 Therapeutics Decreased by AnalystMay 13, 2025 | marketbeat.comC4 Therapeutics (CCCC) Expected to Announce Earnings on WednesdayMay 9, 2025 | marketbeat.comMarshall Wace LLP Has $130,000 Stock Position in C4 Therapeutics, Inc. (NASDAQ:CCCC)May 9, 2025 | marketbeat.comC4 Therapeutics reports Q1 EPS (37c), consensus (42c)May 7, 2025 | msn.comC4 Therapeutics, Inc.: C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 7, 2025 | finanznachrichten.deC4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 7, 2025 | globenewswire.comAdage Capital Partners GP L.L.C. Acquires 1,030,000 Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC)May 1, 2025 | marketbeat.comC4 Therapeutics Inc. CCCC (U.S.: Nasdaq)May 1, 2025 | wsj.comWasatch Advisors LP Raises Stake in C4 Therapeutics, Inc. (NASDAQ:CCCC)April 19, 2025 | marketbeat.comC4 Therapeutics: Getting Too Cheap To Ignore, But There's Still A Lot Of Risk HereMarch 10, 2025 | seekingalpha.comEquities Analysts Offer Predictions for C4 Therapeutics Q2 EarningsMarch 3, 2025 | marketbeat.comC4 Therapeutics, Inc.: C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsMarch 1, 2025 | finanznachrichten.deStifel Nicolaus Reaffirms Their Buy Rating on C4 Therapeutics (CCCC)February 28, 2025 | markets.businessinsider.comC4 Therapeutics (NASDAQ:CCCC) Releases Earnings Results, Misses Expectations By $0.05 EPSFebruary 28, 2025 | marketbeat.comC4 Therapeutics (NASDAQ:CCCC) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPSFebruary 28, 2025 | marketbeat.comC4 Therapeutics Full Year 2024 Earnings: EPS Beats ExpectationsFebruary 28, 2025 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Agilent (A) and C4 Therapeutics (CCCC)February 28, 2025 | markets.businessinsider.comC4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsFebruary 27, 2025 | globenewswire.comC4 Therapeutics to Participate in Upcoming March Investor ConferencesFebruary 24, 2025 | globenewswire.comC4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Consensus Rating of "Moderate Buy" from BrokeragesFebruary 20, 2025 | marketbeat.comC4 Therapeutics, Inc. (NASDAQ:CCCC) Sees Significant Decrease in Short InterestFebruary 16, 2025 | marketbeat.comC4 Therapeutics (CCCC) to Release Quarterly Earnings on ThursdayFebruary 13, 2025 | marketbeat.comC4 Therapeutics stock hits 52-week low at $3.38February 3, 2025 | msn.comC4 Therapeutics announces anticipated 2025 milestonesJanuary 14, 2025 | markets.businessinsider.comC4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in OncologyJanuary 14, 2025 | markets.businessinsider.comC4 Therapeutics price target raised to $50 from $39 at BrooklineJanuary 8, 2025 | markets.businessinsider.comC4 Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 8, 2025 | markets.businessinsider.comEquities Analysts Issue Forecasts for C4 Therapeutics FY2029 EarningsJanuary 8, 2025 | marketbeat.comC4 Therapeutics, Inc. (NASDAQ:CCCC) Short Interest Up 11.0% in DecemberDecember 31, 2024 | marketbeat.comWhy C4 Therapeutics (CCCC) Is One of the Best Biotech Penny Stocks to Invest in Now?December 30, 2024 | msn.comState Street Corp Cuts Position in C4 Therapeutics, Inc. (NASDAQ:CCCC)December 25, 2024 | marketbeat.comWells Fargo Upgrades C4 Therapeutics (CCCC)December 20, 2024 | msn.comC4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Average Recommendation of "Moderate Buy" from AnalystsDecember 20, 2024 | marketbeat.comC4 Therapeutics upgraded to Overweight from Equal Weight at Wells FargoDecember 19, 2024 | markets.businessinsider.comC4 Therapeutics (NASDAQ:CCCC) Upgraded to "Overweight" at Wells Fargo & CompanyDecember 19, 2024 | marketbeat.comFmr LLC Raises Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC)December 17, 2024 | marketbeat.comC4 TherapeuticsDecember 13, 2024 | forbes.comC4 Therapeutics (CCCC) Gets a Hold from Morgan StanleyDecember 10, 2024 | markets.businessinsider.comPoint72 Asset Management L.P. Boosts Stock Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC)December 9, 2024 | marketbeat.comC4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 DegraderDecember 8, 2024 | globenewswire.comC4 Therapeutics, Inc. (NASDAQ:CCCC) Shares Bought by Wasatch Advisors LPDecember 1, 2024 | marketbeat.com Get C4 Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CCCC and its competitors with MarketBeat's FREE daily newsletter. Email Address CCCC Media Mentions By Week CCCC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CCCC News Sentiment▼0.000.57▲Average Medical News Sentiment CCCC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CCCC Articles This Week▼02▲CCCC Articles Average Week Get C4 Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CCCC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fulcrum Therapeutics News Today Revance Therapeutics News Today iTeos Therapeutics News Today Eton Pharmaceuticals News Today Rezolute News Today CryoPort News Today Erasca News Today Vigil Neuroscience News Today Checkpoint Therapeutics News Today Tectonic Therapeutic News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CCCC) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share C4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.